Assyro AI

FDA Orange Book · active-ingredient family

Ketoconazole

Ketoconazole is approved as 6 brand and 22 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:EXTINA · NDA 021738

6

Brand (NDA)

22

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · aerosol, foam, cream, gel, shampoo, suspension, tablet

ProductApplicantApplicationTEApproved
EXTINARLDRISINGNDA 021738Jun 12, 2007
XOLEGELRLDINA PHARMSNDA 021946Jul 28, 2006
NIZORAL ANTI-DANDRUFFRLDKRAMERNDA 020310Oct 10, 1997
NIZORALRLDJANSSEN PHARMSNDA 019927Aug 31, 1990
NIZORALRLDJANSSEN PHARMANDA 019084Dec 31, 1985
NIZORALRLDJANSSEN PHARMSNDA 018533Approved Prior to Jan 1, 1982

Generic (ANDA) products (22)

ProductApplicantApplicationTEApproved
KETOCONAZOLENOVITIUM PHARMAANDA 219129ABJul 03, 2025
KETOCONAZOLEZYDUS LIFESCIENCESANDA 218559ABMar 07, 2025
KETOCONAZOLENOVITIUM PHARMAANDA 218498ABSep 16, 2024
KETOCONAZOLEPADAGIS USANDA 215185Nov 17, 2021
KETOCONAZOLEXIROMEDANDA 213601ABMay 21, 2021
KETOCONAZOLEENCUBEANDA 212443ABMay 20, 2021
KETOCONAZOLESTRIDES PHARMAANDA 210457ABJun 18, 2018
KETOCONAZOLEPADAGIS ISRAELANDA 091550ABAug 25, 2011
KETOCONAZOLECOSETTE PHARMS NCANDA 076942ABApr 11, 2005
KETOCONAZOLEFOUGERA PHARMSANDA 076294ABApr 28, 2004
KETOCONAZOLEPADAGIS ISRAELANDA 076419ABJan 07, 2004
KETOZOLESUN PHARMA CANADAANDA 075638ABDec 18, 2002
KETOCONAZOLESENORES PHARMSANDA 075912ABJan 10, 2002
KETOCONAZOLETEVAANDA 075581ABApr 25, 2000
KETOCONAZOLEAUROBINDO PHARMA USAANDA 075597Dec 23, 1999
KETOCONAZOLEAAIPHARMA LLCANDA 075341Jul 27, 1999
KETOCONAZOLECHARTWELL RXANDA 074971Jun 15, 1999
KETOCONAZOLEHERITAGE PHARMAANDA 075362Jun 15, 1999
KETOCONAZOLESUN PHARM INDUSTRIESANDA 075314Jun 15, 1999
KETOCONAZOLETAROANDA 075319ABJun 15, 1999
KETOCONAZOLETEVAANDA 075273Jun 15, 1999
NIZORALJANSSEN PHARMAANDA 070767Nov 07, 1986

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ketoconazole — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.